Evidence map›Paper›PMID 25766410›Full record

ArticleScientific reports2015

MitoCeption as a new tool to assess the effects of mesenchymal stem/stromal cell mitochondria on cancer cell metabolism and function.

Andrés Caicedo, Vanessa Fritz, Jean-Marc Brondello, Mickaël Ayala, Indira Dennemont, Naoill Abdellaoui, Florence de Fraipont, Anaïck Moisan, Claire Angebault Prouteau, Hassan Boukhaddaoui and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 201 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
201citing papers in PubMed, 3 pooled it
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

201 citing papers in PubMed, 3 syntheses or guidelines pooled it, 327 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. CTRP1 regulates skeletal muscle differentiation through quality control of mitochondrial dynamics and function.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  18. Review
  19. Review
  20. Review

141 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Andrés Caicedo1] IRMB CHU Saint Eloi, 80 rue Augustin Fliche, 34295 Montpellier cedex 5, University of Montpellier, France [2] Inserm U1183,CNRS UMR 5535/IFR122, 1919 route de Mende, 34293 Montpellier Cedex 5, University of Montpellier, France.
Vanessa FritzInstitut de Génétique Moléculaire de Montpellier, CNRS UMR 5535/IFR122, 1919 route de Mende, 34293 Montpellier Cedex 5, University of Montpellier, France.
Jean-Marc Brondello1] IRMB CHU Saint Eloi, 80 rue Augustin Fliche, 34295 Montpellier cedex 5, University of Montpellier, France [2] Inserm U1183,CNRS UMR 5535/IFR122, 1919 route de Mende, 34293 Montpellier Cedex 5, University of Montpellier, France.
Mickaël Ayala1] IRMB CHU Saint Eloi, 80 rue Augustin Fliche, 34295 Montpellier cedex 5, University of Montpellier, France [2] Inserm U1183,CNRS UMR 5535/IFR122, 1919 route de Mende, 34293 Montpellier Cedex 5, University of Montpellier, France.
Indira Dennemont1] IRMB CHU Saint Eloi, 80 rue Augustin Fliche, 34295 Montpellier cedex 5, University of Montpellier, France [2] Inserm U1183,CNRS UMR 5535/IFR122, 1919 route de Mende, 34293 Montpellier Cedex 5, University of Montpellier, France.
Naoill Abdellaoui1] IRMB CHU Saint Eloi, 80 rue Augustin Fliche, 34295 Montpellier cedex 5, University of Montpellier, France [2] Inserm U1183,CNRS UMR 5535/IFR122, 1919 route de Mende, 34293 Montpellier Cedex 5, University of Montpellier, France.
Florence de Fraipont1] Univ Grenoble Alpes, 38000 Grenoble, France [2] Inserm, U823 and U836, 38000 Grenoble, France [3] Grenoble University hospital, Institut of Biologie and Pathology, 38000 Grenoble, France.
Anaïck Moisan1] Univ Grenoble Alpes, 38000 Grenoble, France [2] Inserm, U823 and U836, 38000 Grenoble, France [3] French blood company/Grenoble University hospital, Cell Therapy Unit, 38000 Grenoble, France.
Claire Angebault Prouteau1] IRMB CHU Saint Eloi, 80 rue Augustin Fliche, 34295 Montpellier cedex 5, University of Montpellier, France [2] Inserm U1051, Montpellier, France.
Hassan Boukhaddaoui1] IRMB CHU Saint Eloi, 80 rue Augustin Fliche, 34295 Montpellier cedex 5, University of Montpellier, France [2] Inserm U1051, Montpellier, France.
Christian Jorgensen1] IRMB CHU Saint Eloi, 80 rue Augustin Fliche, 34295 Montpellier cedex 5, University of Montpellier, France [2] Inserm U1183,CNRS UMR 5535/IFR122, 1919 route de Mende, 34293 Montpellier Cedex 5, University of Montpellier, France [3] Department for Biotherapy at CHU Lapeyronie University Hospital, Montpellier, France.
Marie-Luce Vignais1] IRMB CHU Saint Eloi, 80 rue Augustin Fliche, 34295 Montpellier cedex 5, University of Montpellier, France [2] Inserm U1183,CNRS UMR 5535/IFR122, 1919 route de Mende, 34293 Montpellier Cedex 5, University of Montpellier, France.
Université de Montpellier · FRCentre National de la Recherche Scientifique · FRUniversité Grenoble Alpes · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitochondrial activity is central to tissue homeostasis. Mitochondria dysfunction constitutes a hallmark of many genetic diseases and plays a key role in tumor progression. The essential role of mitochondria, added to their recently documented capacity to transfer from cell to cell, obviously contributes to their current interest. However, determining the proper role of mitochondria in defined biological contexts was hampered by the lack of suitable experimental tools. We designed a protocol (MitoCeption) to directly and quantitatively transfer mitochondria, isolated from cell type A, to recipient cell type B. We validated and quantified the effective mitochondria transfer by imaging, fluorescence-activated cell sorting (FACS) and mitochondrial DNA analysis. We show that the transfer of minute amounts of mesenchymal stem/stromal cell (MSC) mitochondria to cancer cells, a process otherwise occurring naturally in coculture, results in cancer cell enhanced oxidative phosphorylation (OXPHOS) activity and favors cancer cell proliferation and invasion. The MitoCeption technique, which can be applied to different cell systems, will therefore be a method of choice to analyze the metabolic modifications induced by exogenous mitochondria in host cells.

Indexed as

Adenosine TriphosphateCell Line, TumorCell MovementCell ProliferationCoculture TechniquesFlow CytometryHumansMesenchymal Stem CellsMetabolomicsMitochondriaNeoplasmsReproducibility of ResultsTime-Lapse ImagingAdenosine Triphosphate

Identifiers

PMID25766410
PMCPMC4358056
OpenAlexW2085142263

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.